dc.creator | Cavalcanti, A. | |
dc.creator | Santos, R. | |
dc.creator | Mesquita, Z. | |
dc.creator | Duarte, A. L. B. P. | |
dc.creator | Lucena-Silva, N. | |
dc.date | 2017-06-21T17:58:17Z | |
dc.date | 2017-06-21T17:58:17Z | |
dc.date | 2017 | |
dc.date.accessioned | 2023-09-26T20:26:43Z | |
dc.date.available | 2023-09-26T20:26:43Z | |
dc.identifier | CAVALCANTI, A. et al. Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study. Brazilian Journal of Medical and Biological Research, v. 50, n. 4, 2017. | |
dc.identifier | 1414-431X | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/19475 | |
dc.identifier | 10.1590/1414-431X20175738 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8857058 | |
dc.description | Childhood-onset systemic lupus erythematosus (cSLE) exhibits an aggressive clinical phenotype and severe complications. This could be due to a pro-inflammatory cytokine milieu. Therefore, we determined plasma levels of Th1 (IL-2, IFN-γ, TNF), Th2 (IL-4), Th17 (IL-17A, IL-6), and Treg (IL-10) cytokines in a cohort of cSLE patients and healthy controls, and we evaluated the association between these cytokines and disease activity. We conducted a cross-sectional study with 51 cSLE patients from two pediatric rheumatology services. Ten cSLE patients participated in a longitudinal follow-up study. Blood samples were collected from the same patient during active and inactive disease. Disease activity was evaluated according to SLE Disease Activity Index 2000 (SLEDAI-2K). Cytokines levels were measured by cytometric bead array technique. cSLE patients had higher IL-6 (P<0.001) and IL-10 (P<0.001) levels than healthy controls. Patients with active disease had higher IL-6 and IL-10 levels than patients with inactive disease (P=0.001 and P=0.014, respectively) and the control group (both P<0.001). IL-6 (P=0.022), IL-10 (P=0.013), and IL-17A (P=0.041) levels were significantly higher during active than inactive disease. Linear regression analysis revealed IL-6 (P=0.002, 95%CI=0.006-0.025) and IL-10 (P=0.01 95%CI=0.021-0.150) as independent factors for increased SLEDAI-2K. IL-6, IL-10, and IL-17A are candidate biomarkers for disease activity in cSLE patients. This is the first longitudinal study to support their pivotal role in the pathogenesis of the disease. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.rights | open access | |
dc.subject | Citocinas | |
dc.subject | Lúpus eritematoso sistêmico de início na infância | |
dc.subject | Atividade de doença | |
dc.subject | SLEDAI-2K | |
dc.subject | Inflamação | |
dc.subject | Cytokines | |
dc.subject | Childhood-onset systemic lupus erythematosus | |
dc.subject | Disease activity | |
dc.subject | SLEDAI-2K | |
dc.subject | Inflammation | |
dc.subject | Lúpus Eritematoso Sistémico , Sistémico / sangue | |
dc.subject | Citocinas / sangue | |
dc.title | Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study | |
dc.type | Article | |